1. Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches

   • A. J. Schrader
   • Z. Varga
   • R. Hofmann

   Review 25 November 2005 Pages: 137 - 149

   

2. Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines

   • Megumi Senju
   • Naoko Sueoka
   • Eisaburo Sueoka

   Original Paper 09 November 2005 Pages: 150 - 158

   

3. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients

   • Linnea M. Baudhuin
   • Lewis R. Roberts
   • W. Edward Highsmith

   Original Paper 15 November 2005 Pages: 159 - 162

   

4. Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer

   • Annette Schmider-Ross
   • Olaf Pirsig
   • Angela Reles

   Original Paper 19 November 2005 Pages: 163 - 170

   

5. Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells

   • Nagathihalli S. Nagaraj
   • Nadarajah Vigneswaran
   • Wolfgang Zacharias

   Original Paper 16 December 2005 Pages: 171 - 183

   

6. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells

   • Joong-Won Park
   • Jung Eun Park
   • Chang-Min Kim

   Original Paper 06 December 2005 Pages: 184 - 192

   

7. Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population

   • Jing Jiang
   • Jingweng Wang
   • Shinkan Tokudome

   Original Paper 03 December 2005 Pages: 193 - 199

8. Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms

   • Tamara Čačev
   • Mladen Jokić
   • Sanja Kapitanović

   Original Paper 08 November 2005 Pages: 200 - 204